Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mimedx (MDXG) Change in Inventory (2016 - 2025)

Historic Change in Inventory for Mimedx (MDXG) over the last 15 years, with Q3 2025 value amounting to $1.6 million.

  • Mimedx's Change in Inventory rose 29975.22% to $1.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.3 million, marking a year-over-year decrease of 5252.63%. This contributed to the annual value of $2.4 million for FY2024, which is 6992.86% down from last year.
  • Per Mimedx's latest filing, its Change in Inventory stood at $1.6 million for Q3 2025, which was up 29975.22% from $820000.0 recorded in Q2 2025.
  • In the past 5 years, Mimedx's Change in Inventory ranged from a high of $2.9 million in Q1 2024 and a low of -$1.4 million during Q2 2021
  • In the last 5 years, Mimedx's Change in Inventory had a median value of $820000.0 in 2025 and averaged $846842.1.
  • As far as peak fluctuations go, Mimedx's Change in Inventory tumbled by 23870.4% in 2022, and later skyrocketed by 91839.62% in 2023.
  • Quarter analysis of 5 years shows Mimedx's Change in Inventory stood at $571000.0 in 2021, then crashed by 238.7% to -$792000.0 in 2022, then skyrocketed by 346.59% to $2.0 million in 2023, then tumbled by 122.53% to -$440000.0 in 2024, then surged by 466.36% to $1.6 million in 2025.
  • Its last three reported values are $1.6 million in Q3 2025, $820000.0 for Q2 2025, and $263000.0 during Q1 2025.